Responses
Mental health
Protocol
Treatment of antipsychotic-associated obesity with a GLP-1 receptor agonist—protocol for an investigator-initiated prospective, randomised, placebo-controlled, double-blinded intervention study: the TAO study protocol
Compose a Response to This Article
Other responses
No responses have been published for this article.